Literature DB >> 25341366

Biomarkers in heart failure.

Yasuchika Takeishi1.   

Abstract

Appropriate use of biomarkers is clinically important for identifying heart failure in its early stage, optimizing risk stratification, and managing patients. This article describes established and traditional biomarkers as well as novel biomarkers reflective of myocardial stress, myocardial damage, extracellular matrix, oxidative stress, inflammation, renal function, micro RNAs, and heart failure with preserved left ventricular ejection fraction. This review focuses on the recent advances in cardiac and non-cardiac biomarkers of heart failure and their appropriate use in clinical practice.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25341366     DOI： 10.1536/ihj.14-267

Source DB:  PubMed          Journal:  Int Heart J        ISSN： 1349-2365            Impact factor:   1.862


  7 in total

1.  Downregulation of Talin-1 is associated with the increased expression of miR-182-5p and miR-9-5p in coronary artery disease.

Authors:  Akram Gholipour; Farshad Shakerian; Ali Zahedmehr; Shiva Irani; Seyed Javad Mowla; Mahshid Malakootian
Journal:  J Clin Lab Anal       Date:  2022-02-14       Impact factor: 2.352

2.  Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.

Authors:  Piercarlo Ballo; Irene Betti; Alessandro Barchielli; Daniela Balzi; Gabriele Castelli; Leonardo De Luca; Mihai Gheorghiade; Alfredo Zuppiroli
Journal:  Clin Res Cardiol       Date:  2015-11-07       Impact factor: 5.460

Review 3.  Emerging biomarkers in heart failure and cardiac cachexia.

Authors:  Goran Loncar; Daniel Omersa; Natasa Cvetinovic; Aleksandra Arandjelovic; Mitja Lainscak
Journal:  Int J Mol Sci       Date:  2014-12-22       Impact factor: 5.923

4.  Plasma brain natriuretic peptide level in older outpatients with heart failure is associated with physical frailty, especially with the slowness domain.

Authors:  Shu Nishiguchi; Yuma Nozaki; Masayuki Yamaji; Kanako Oya; Yuki Hikita; Tomoki Aoyama; Hiroshi Mabuchi
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

Review 5.  MicroRNA Regulation of Epithelial to Mesenchymal Transition.

Authors:  Mohammed L Abba; Nitin Patil; Jörg Hendrik Leupold; Heike Allgayer
Journal:  J Clin Med       Date:  2016-01-14       Impact factor: 4.241

6.  Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial.

Authors:  Satoshi Suzuki; Akiomi Yoshihisa; Tetsuro Yokokawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Akihiro Tsuda; Tatsunori Tsuda; Toshiyuki Ishibashi; Ichiro Konno; Osamu Yamaguchi; Hirofumi Machii; Naoki Nozaki; Takeshi Niizeki; Takuya Miyamoto; Yasuchika Takeishi
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

Review 7.  New Treatment Strategies for Alcohol-Induced Heart Damage.

Authors:  Joaquim Fernández-Solà; Ana Planavila Porta
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.